EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lipoprotein(a) and cardiovascular disease

Michael B Boffa iD, Marlys L Koschinsky

Biochemical Journal · 02.10.2024 · 481 (19) · 1277-1296

DOI: 10.1042/bcj20240037 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Journal, online erschienen am 20.09.2024. Verfasst von Michael B Boffa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Western Ontario, London, Ontario, Canada. Hauptthemen laut MEDLINE: Lipoprotein(a), Cardiovascular Diseases. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Elevated plasma levels of lipoprotein(a) (Lp(a)) are a prevalent, independent, and causal risk factor for atherosclerotic cardiovascular disease and calcific aortic valve disease. Lp(a) consists of a lipoprotein particle resembling low density lipoprotein and the covalently-attached glycoprotein apolipoprotein(a) (apo(a)). Novel therapeutics that specifically and potently lower Lp(a) levels are currently in advanced stages of clinical development, including in large, phase 3 cardiovascular outcomes trials. However, fundamental unanswered questions remain concerning some key aspects of Lp(a) biosynthesis and catabolism as well as the true pathogenic mechanisms of the particle. In this review, we describe the salient biochemical features of Lp(a) and apo(a) and how they underlie the disease-causing potential of Lp(a), the factors that determine plasma Lp(a) concentrations, and the mechanism of action of Lp(a)-lowering drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoprotein(a)Cardiovascular DiseasesHumansAnimalsAtherosclerosis

Stichwörter der Autor:innen

apolipoprotein(a)atherosclerotic cardiovascular diseasecalcific aortic valve diseaselipoprotein metabolismlipoprotein(a)thrombosis

Substanzen

Lipoprotein(a)

Autor:innen und Institutionen

  • Department of Biochemistry, University of Western Ontario, London, Ontario, Canada.
  • Robarts Research Institute, University of Western Ontario, London, Ontario, Canada.
  • Department of Physiology and Pharmacology, University of Western Ontario, London, Ontario, Canada.

ORCID-Profile: Michael B Boffa

Zitieren

APA

Boffa, M. B., & Koschinsky, M. L. (2024). Lipoprotein(a) and cardiovascular disease. Biochemical Journal, 481(19), 1277-1296. https://doi.org/10.1042/bcj20240037

Vancouver

Boffa MB, Koschinsky ML. Lipoprotein(a) and cardiovascular disease. Biochemical Journal. 2024;481(19):1277-1296. doi:10.1042/bcj20240037

BibTeX
@article{Boffa2024,
  author = {Boffa, Michael B and Koschinsky, Marlys L},
  title = {Lipoprotein(a) and cardiovascular disease},
  journal = {Biochemical Journal},
  year = {2024},
  volume = {481},
  number = {19},
  pages = {1277--1296},
  doi = {10.1042/bcj20240037}
}
Kostenlos starten →